Bruker Corporation Stock

$31.81

3.35% today

Nasdaq, Aug 12, 07:46 pm CET

ISIN

US1167941087

Symbol

BRKR

Reports

Quarter | Annual

Index

NASDAQ Composite, S&P MidCap 400

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Life Sciences Tools & Services

Overview Dividends Analysts Charts News Strategies

Bruker Corporation Stock price

$30.78

-12.86 29.47% 5Y

Nasdaq, Closing price Mon, Aug 11 2025

+0.35 1.15%

ISIN

US1167941087

Symbol

BRKR

Reports

Quarter | Annual

Index

NASDAQ Composite, S&P MidCap 400

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Life Sciences Tools & Services

Key metrics

Basic

Market capitalization

$4.7b

Enterprise Value

$7.0b

Net debt

$2.3b

Cash

$92.0m

Shares outstanding

151.7m

Valuation (TTM | estimate)

P/E

59.2 | 12.4

P/S

1.4 | 1.3

EV/Sales

2.0 | 2.0

EV/FCF

142.3

P/B

2.6

Dividends

DPS

$0.20

Yield 1Y | 5Y

0.7% | 0.3%

Growth 1Y | 5Y

0.0% | 4.6%

Payout 1Y | 3Y

26.3% | 10.6%

Increased

0 Years

Financials (TTM | estimate)

Revenue

$3.4b | $3.6b

EBITDA

$544.0m | $623.3m

EBIT

$333.6m | $492.9m

Net Income

$79.6m | $377.1m

Free Cash Flow

$49.3m

Growth (TTM | estimate)

Revenue

10.4% | 6.5%

EBITDA

-3.9% | 9.2%

EBIT

-20.9% | 27.4%

Net Income

-77.4% | 233.4%

Free Cash Flow

-70.7%

Financial Health

Equity Ratio

30.7%

Return on Equity

6.4%

ROCE

6.7%

ROIC

3.7%

Debt/Equity

1.3

EPS

$0.5

FCF per Share

$0.3

Short interest

13.5%

Employees

11k

Rev per Employee

$300.0k

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

Get Started for Free Today

Bruker Corporation Stock Analysis

Unlock Scores for Free

??

21 Analysts have issued a Bruker Corporation forecast:

12x Buy

57%

8x Hold

38%

More details on Analyst Estimates Including Price Targets

21 Analysts have issued a Bruker Corporation forecast:

Buy

57%

Hold

38%

Sell

Analyst Estimates with Stock Price Targets

Financial data from Bruker Corporation

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Jun '25		+/- %
Revenue	3,443 3,443	10% 10% 100%
- Direct Costs	1,772 1,772	14% 14% 51%
Gross Profit	1,671 1,671	7% 7% 49%
- Selling and Administrative Expenses	934 934	16% 16% 27%
- Research and Development Expense	400 400	22% 22% 12%
EBITDA	544 544	4% 4% 16%
- Depreciation and Amortization	210 210	46% 46% 6%
EBIT (Operating Income) EBIT	334 334	21% 21% 10%
Net Profit	80 80	77% 77% 2%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Bruker Corporation Stock News

Neutral

Business Wire

●

about 7 hours ago

Bruker Announces Quarterly Dividend

BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.05 per share on the Company's common stock. The dividend will be paid on October 3, 2025 to stockholders of record as of September 23, 2025. About Bruker Corporation – Leader of the Post-Genomic Era...

Neutral

Business Wire

●

6 days ago

Bruker Secures Multi-Year Contracts for Explosives and Chemical Trace Detection in Aviation and Defense Sectors

ETTLINGEN, Germany--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced the signing of multiple new contracts and framework agreements for its explosives and chemical trace detection solutions, accessories, consumables, and service offerings. Finalized throughout 2025, these agreements represent a total order volume of over $27 million year-to-date in 2025, suppor...

Neutral

Seeking Alpha

●

8 days ago

Bruker Corporation (BRKR) Q2 2025 Earnings Call Transcript

Bruker Corporation (NASDAQ:BRKR ) Q2 2025 Earnings Conference Call August 4, 2025 8:30 AM ET Company Participants Frank H. Laukien - Chairman, CEO & President Gerald N.

More Bruker Corporation News

Company Profile

Bruker Corp. engages in the development, manufacture, and distribution of scientific instruments, and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. It operates through the Bruker Scientific Instruments (BSI), and Bruker Energy and Supercon Technologies (BEST) segments. The BSI segment comprises of the Bruker BioSpin Group, the Bruker CALID Group, and the Bruker Nano Group. The BEST segment designs, manufactures, and distributes superconducting materials, primarily metallic low temperature superconductors, for use in magnetic resonance imaging, nuclear magnetic resonance, fusion energy research and other applications. The company was founded by Gunther Laukien in 1961 and is headquartered in Billerica, MA.

Head office	United States
CEO	Frank Laukien
Employees	11,396
Founded	1960
Website	www.bruker.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now